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ABSTRACT Lipid bilayer membranes composed of DOPC, DPPC, and a series of sterols demix into coexisting liquid phases
below a miscibility transition temperature. We use ﬂuorescence microscopy to directly observe phase transitions in vesicles of
1:1:1 DOPC/DPPC/sterol within giant unilamellar vesicles. We show that vesicles containing the ‘‘promoter’’ sterols cholesterol,
ergosterol, 25-hydroxycholesterol, epicholesterol, or dihydrocholesterol demix into coexisting liquid phases as temperature is
lowered through the miscibility transition. In contrast, vesicles containing the ‘‘inhibitor’’ sterols androstenolone, coprostanol,
cholestenone, or cholestane form coexisting gel (solid) and liquid phases. Vesicles containing lanosterol, a sterol found in the
cholesterol and ergosterol synthesis pathways, do not exhibit coexisting phases over a wide range of temperatures and
compositions. Although more detailed phase diagrams and precise distinctions between gel and liquid phases are required to
fully deﬁne the phase behavior of these sterols in vesicles, we ﬁnd that our classiﬁcations of promoter and inhibitor sterols are
consistent with previous designations based on ﬂuorescence quenching and detergent resistance. We ﬁnd no trend in the
liquid-liquid or gel-liquid transition temperatures of membranes with promoter or inhibitor sterols and measure the surface
fraction of coexisting phases. We ﬁnd that the vesicle phase behavior is related to the structure of the sterols. Promoter sterols
have ﬂat, fused rings, a hydroxyl headgroup, an alkyl tail, and a small molecular area, which are all attributes of ‘‘membrane
active’’ sterols.
INTRODUCTION
All vertebrates synthesize cholesterol (1), which is found pre-
dominantly in the plasma membranes of cells (2). Choles-
terol has at least two classes of important functions. First,
it controls metabolic processes and is a speciﬁc precursor of
D-vitamins, sex hormones, and bile acids (1). However, the
amount of cholesterol in animal tissues is much higher than
needed in these roles. Another function of cholesterol may be
to alter the properties of lipids in membranes (1). Above the
lipid melting temperature, the presence of cholesterol orders
lipid acyl chains. Below the melting temperature, cholesterol
prevents lipids from condensing into solid phases. Further-
more, the addition of cholesterol to lipid mixtures promotes
the formation of two coexisting liquid phases, a familiar
‘‘liquid crystalline’’ (La) phase and a ‘‘liquid-ordered’’ (Lo)
phase (3,4). The liquid-ordered phase has been distinguished
from a solid phase by faster translational diffusion of the
lipids (5) and greater mobility of the acyl chains (6). The sep-
aration of lipids into two immiscible liquid phases is often
linked to the formation of ‘‘rafts’’ in cell membranes (7).
These raft domains are characterized as rich in cholesterol
and saturated lipids, and they have been implicated in a host
of important cell functions such as membrane trafﬁcking and
signaling (8).
Although it is known that lipids and sterols interact in
membranes through hydrogen bonding and van der Waals
forces, little is known about how these interactions give rise
to immiscible liquid phases in bilayers (7). To directly probe
how sterol structure affects the miscibility phase behavior
of lipids, we incorporated the sterols in Fig. 1 into giant
unilamellar vesicles (GUVs) and utilized ﬂuorescence mi-
croscopy to observe micron-scale domains of coexisting
phases.
We chose some of the sterols because they are naturally
related to cholesterol. For example, lanosterol is a precursor
of both cholesterol, which is found primarily in animal
tissue, and ergosterol, which is found primarily in yeast and
fungi (1). The sterol 25-hydroxycholesterol is an inhibitor of
HMG-CoA reductase and in turn prevents the synthesis of
cholesterol (1). Cholesterol oxidase catalyzes the conversion
of cholesterol to cholestenone (9). Finally, as its name sug-
gests, coprostanol appears in feces and arises due to the con-
version of cholesterol by bacteria (10).
In our experiments, we use ﬂuorescence microscopy to
directly observe micron-scale domains in membranes con-
taining equimolar ratios of the saturated lipid DPPC
(dipalmitoyl phosphatidylcholine), the unsaturated lipid
DOPC (dioleoyl phosphatidylcholine), and a sterol. We
classify sterols as promoters if vesicles contain immiscible
liquid phases as temperature is lowered. Vesicles made with
inhibitor sterols instead form coexisting solid and liquid
phases as temperature is lowered. We measure the transition
temperature (miscibility or melting) of vesicles containing
different sterols and determine the area fraction of the more
ordered phase. Our ﬁndings are consistent with previouswork
that classiﬁed the sterols used as either promoters or inhibitors
of ordered membrane domains using ﬂuorescence quenching
and detergent resistance (4,11).
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MATERIALS AND METHODS
Transition temperatures
The lipids DOPC and DPPC have gel phase melting temperatures of 20C
and 41C, respectively (12), and were obtained from Avanti Polar Lipids
(Alabaster, AL). Androstenolone (5-androsten-3b-ol-17-one), coprostanol
(5b-cholestan-3b-ol), cholestenone (4-cholesten-3-one), cholestane (5a-
cholestane), and epicholesterol (5-cholesten-3a-ol) were obtained from
Steraloids (Newport, RI). Cholesterol (5-cholesten-3b-ol), dihydrocholes-
terol (5a-cholestan-3b-ol), ergosterol, lanosterol, and 25-hydroxycholesterol
were obtained from Sigma (St. Louis, MO). The dye Texas Red DPPE
(TR-DPPE) was purchased from Molecular Probes (Eugene, OR) and was
used for contrast between membrane domains. Vesicles were produced with
33 mol % sterol because vesicles of 1:1:1 DOPC/DPPC/cholesterol are
comfortably far from the gel phase transition that appears at low sterol
concentrations (13) and from the solubility limit of cholesterol in vesicles
at high sterol concentrations (14). We have no data for solubility limits for
other sterols, although evidence suggests that the solubility limit of epicho-
lesterol may be below 33 mol % (15).
GUVs of 1:1:1 DPPC/DOPC/sterol and 0.8 mol % TR-DPPE were
prepared by electroformation at 60C in deionized water (18 MV-cm,
Barnstead, Dubuque, IA) as described previously (16,17). The resultant
vesicles were transferred between glass coverslips for examination by
ﬂuorescence microscopy on a temperature controlled microscope stage. The
vesicles were free ﬂoating and not attached either to the glass slide or to
other vesicles. The phase transition in a single vesicle is identiﬁed as the
temperature at which domains of at least 1 mm appear (or disappear) in the
membrane as temperature is lowered (or raised). Temperature was ramped at
0.2C/s and the sample equilibrated for 30 s before viewing. The lowest
temperature probed was 10C. All transitions are fully reversible. Errors bars
reported in transition temperature represent the full range of temperatures
over which many vesicles pass through the transition in a single preparation
of GUVs. The measured range of transition temperatures is reproducible
when vesicles are prepared with the same initial lipid composition and
experimental conditions (e.g., growth temperature). The spread in transition
temperature between vesicles is due to variation in lipid composition and the
location of that composition with respect to the nearest phase boundary.
Previously we have noted that there is increased spread in measured
transition temperatures near steep regions of the phase diagram, where small
changes in lipid composition can lead to large changes in transition
temperature (18). The midpoint of this range (black points in Fig. 2) roughly
corresponds to the temperature at which 50% of vesicles contain coexisting
phases. The spread in transition temperature is unusually large for
membranes containing the sterol 25-OH-cholesterol (DT ¼ 22C). This
sample contains some vesicles with a transition close to the growth
temperature. Previously we have observed a large distribution in transition
temperatures for vesicles of 1:1 DOPC/DPPC 1 35% cholesterol when
vesicles are grown at or below their miscibility transition temperature
(19,25).
Area fractions
Vesicles were quenched from one uniform phase at 60C to the temperature
of the equilibrated microscope stage (either 23C or 29C). Images of each
vesicle hemisphere were collected after an equilibration time of roughly
1 min. The area fraction of dark phase was evaluated as described previously
(20); namely, boundaries between bright and dark phases were determined
by hand, a threshold was applied to the images to result in only black and
white pixels, and the number of pixels were added (without geometric
correction) to yield an area fraction of dark phase. Area fractions were added
for both hemispheres of the vesicle and then averaged over multiple vesicles
for each sterol at each temperature. Error bars represent the standard devia-
tion of the mean ðerror ¼ s= ﬃﬃﬃﬃNp Þ; and the number of vesicles analyzed (N)
is shown in Table 1. Similar standard deviations in area fraction have been
found in vesicles grown by electroformation on a wire and imaged by
confocal microscopy, including geometric corrections (Vernita Gordon and
Paul Beales, University of Edinburgh, personal communication, 2005). We
estimate a systematic error of #20% between area fractions determined by
individual researchers due to the qualitative identiﬁcation of domain
boundaries, although trends in area fraction are not affected (20).
Solid versus liquid
We characterize domains as either solid (gel) or liquid based on domain
shape and the kinetics of domain coalescence. All domains identiﬁed as
solid in this work are noncircular. Liquid domains are circular and usually
coalesce quickly upon colliding, typically within seconds. All systems
studied here except one (vesicles containing 25-hydroxycholesterol at 23C)
fall clearly into these two categories. In the case of 25-hydroxycholesterol,
vesicles clearly exhibit liquid phases at 29C. At 23C, domains in these
FIGURE 1 Sterol structures drawn to high-
light assignment of hydrogen, hydroxy, and
methyl groups to either the a-face (bottom) or
b-face (top) of the sterol. Distortion of the rings
due to double bonds is not shown for the sterols
ergosterol and lanosterol.
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same vesicles coalesced more slowly, within minutes rather than within
seconds. Based on known diffusion constants (below) we reasoned that since
two domains at 23C coalesced completely within several minutes in
vesicles containing 25-hydroxycholesterol, the domains probably contain
a liquid phase.
Our characterization of liquid versus solid phases for the particular case
of vesicles containing 25-hydroxycholesterol is based on lipid mobility and
is consistent with previous measurements of lipid diffusion. Lipid diffusion
constants (D) have been measured in liquid states (both Lo and La) by
a variety of experimental methods to be;1–20 mm2/s (5,21–23). Therefore,
the time required for a lipid to traverse a micron across the membrane’s
surface ranges between seconds and hundredths of seconds. In contrast,
lipids in So states diffuse signiﬁcantly slower (D ; 10
2  108 mm2/s)
(5,22,24), leading to much longer timescales for mm-scale lipid motion,
from hundreds of seconds to hundreds of days. Interestingly, binary
membranes of saturated lipids and cholesterol with So-Lo coexistence also
show slow diffusion (D; 1–53 102 mm2/s) (5,23), and large-scale phase
separation is not detected by ﬂuorescence microscopy (16). For this reason,
we are unable to distinguish pure So domains from domains containing both
So and Lo phases in this study, although it is a focus of current work in our
laboratory. We have discussed So-Lo coexistence and evidence for three
phase So-Lo-La coexistence in greater detail in the context of mixtures
containing sphingomyelin lipids and cholesterol (19,25).
RESULTS
To study the inﬂuence of different sterols on lipid phase
behavior, we produced free-ﬂoating GUVs containing
equimolar ratios of DOPC, DPPC, and each of the sterols
shown in Fig. 1. The lipids DOPC and DPPC were chosen
because they are readily available as pure, single compo-
nents, and we have studied the ternary mixture of DOPC/
DPPC/cholesterol extensively (16,20).
Membranes in the presence and absence
of cholesterol
When vesicles are produced from an equimolar mixture of
DOPC, DPPC, and cholesterol, coexisting liquid phases are
observed below the miscibility transition temperature (Fig. 2).
Liquid domains are large and circular when imaged well
below the miscibility transition temperature (Fig. 3) and two
domains coalesce quickly upon collision (typically ,1 s). In
vesicles containing cholesterol, liquid domains ripen through
coalescence until vesicles contain only one bright domain
and one dark domain (16). This ripening and completion of
phase separation typically occurs within minutes. We have
previously shown that the bright phase is rich in unsaturated
lipid (DOPC) in a liquid-crystalline state, whereas the dark
phase is rich in saturated lipid (DPPC) and cholesterol and
is in a liquid-ordered state (20). Other lipid mixtures produce
similar phase behavior. Coexisting liquid phases are ob-
served in a wide variety of ternary mixtures of saturated
lipids, unsaturated lipids, and cholesterol (16).
In the absence of cholesterol, vesicles of DOPC and DPPC
contain coexisting solid and liquid phases below the melting
transition temperature (Fig. 3 f) (16,26). A dark domain is
clearly solid rather than liquid if it has a static, noncircular
boundary. The dark solid phase is rich in saturated lipid, and
the bright liquid phase is rich in unsaturated lipid and the
ﬂuorescent dye (16).
Membranes containing other sterols
It is argued that cholesterol is necessary to form the liquid-
ordered phase in membranes. Speciﬁc interactions between
cholesterol and saturated lipids lead to an average ordering of
the acyl chains while maintaining the liquid state of the mem-
brane (3). Here we demonstrate that other sterols besides
cholesterol promote micron-scale coexisting liquid phases in
lipid membranes.
Vesicles of DOPC, DPPC, and the various sterols in Fig. 1
exhibit either two coexisting liquid phases or coexisting solid
and liquid phases at low temperatures. Above the transition
temperatures shown in Fig. 2, vesicles are in one uniform
liquid phase. Vesicles containing the sterols 25-hydroxy-
cholesterol, cholesterol, dihydrocholesterol, epicholesterol,
or ergosterol produce coexisting liquid phases below a mis-
cibility transition (Fig. 3, a–e). We classify these sterols as
promoters because they promote the formation of a second
liquid phase as cholesterol does. In contrast, we observe a
transition to coexisting solid and liquid phases in vesicles
containing the sterols androstenolone, cholestane, choles-
tenone, or coprostanol (Fig. 3, g–j). We classify these sterols
as inhibitors because they do not promote the formation of
a second liquid phase. The remaining sterol, lanosterol, does
FIGURE 2 Transition temperatures of vesicles produced from 1:1:1
DOPC/DPPC/sterol with 0.8 mol % TR-DPPE. As temperature is decreased,
a transition is observed from one uniform phase to either (middle) two
coexisting liquid phases for vesicles containing promoter sterols or (right)
a solid and liquid phase for vesicles containing inhibitor sterols. No
correlation is seen between the type of transition and the transition
temperature.
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not produce coexisting liquid or coexisting solid and liquid
phases over a wide range of temperatures (5C–60C) and
lipid compositions (DOPC/DPPC/lanosterol with ratios 33/
33/33, 35/35/30, 37/38/25, 22/45/33, and 24/49/27). Coex-
isting liquid domains can be induced in membranes con-
taining lanosterol by exposure to light. Previously we noted
that light can induce coexisting liquid domains in vesicles
containing DOPC, DPPC, and cholesterol near the mis-
cibility transition boundary (16).
We ﬁnd no distinct correlation between transition temper-
atures and the phases produced, solid domains for the in-
hibitor sterols, and coexisting liquid phases for the promoters
(Fig. 2). When a solid phase is formed, transition temper-
atures are lower than for pure DPPC (41C), as expected
from a colligative melting point depression due to the addi-
tion of DOPC and sterol to the membrane. Liquid miscibility
transition temperatures are not constrained to be below the
melting point of pure DPPC, although they generally fall
below 41C. Vesicles that exhibit liquid miscibility tran-
sitions may also have melting transitions to solid phases at
lower temperatures, including coexistence of three phases
containing a solid with two distinct liquids (19,25). We ﬁnd
no direct evidence for a gel phase in vesicles containing
promoter sterols down to 23C, except perhaps in mem-
branes containing 25-hydroxycholesterol, in which the
coalescence of two dark, circular domains at 23C requires
;1 min (see partially coalesced domains in Fig. 3 a and the
Materials and Methods section). It is useful to relate these
results to membranes containing cholesterol in which slow
domain coalescence is observed in regions of the phase
diagram where there is evidence for coexisting So, Lo, and La
phases (S. L. Veatch and S. L. Keller, unpublished results,
and (25)).
Based on our previous results with membranes containing
cholesterol (16), we conclude that the lipids in the dark
domains in Fig. 3 are more ordered and contain more DPPC,
whether those domains are solid or liquid. Area fractions of
dark phases for vesicles containing each sterol are shown in
Fig. 4. For the most part, vesicles containing solid domains
with inhibitor sterols have smaller areas of dark phase than
liquid domains with promoter sterols. This difference in area
fraction is consistent with a smaller molecular area in solid
phases than in liquid phases. In addition, solid phases should
contain little sterol (27), whereas ordered liquid phases can
incorporate signiﬁcant fractions of sterol (20). By extension,
inhibitor sterols are expected to have low solubility in DPPC
below its melting temperature. The fraction of solid phase in
vesicles with inhibitor sterols in Fig. 4 follows the trend in
melting temperature in Fig. 2. This is simply explained by an
increase in solid phase as temperature is lowered further
below the melting temperature. Similarly, as temperature
decreases from 29C to 23C, the fraction of dark area in
vesicles either remains constant or increases (Fig. 4). This is
consistent with our previous observations in vesicles of
DOPC/DPPC/cholesterol (20).
We would like to emphasize that we measure transition
temperatures and dark phase surface fractions at a single
point in the ternary phase diagram for each sterol system and
do not attempt to map entire miscibility phase boundaries. It
is important not to draw too much signiﬁcance from a single
data point. Although higher transition temperatures could be
due to an increased interaction energy between the sterol and
saturated lipid DPPC, it could also indicate that the phase
boundary is shifted to higher sterol concentrations or that
,33% sterol partitions into the membrane. Similarly, a wide
spread in transition temperatures could be due to the close
proximity of a steep region of the phase diagram. A wide
spread may also indicate that the sterol produces nonuniform
ﬁlms during preparation or that vesicles of that sterol should
be grown at alternate temperatures (19). Clearly, studies over
a range of lipid compositions are necessary to make direct
comparisons between individual sterols. Our results provide
a ﬁrst step toward those broad studies.
We also investigated the effect of gradually substituting
cholestenone for cholesterol in vesicles (Fig. 5). The activity
of cholesterol oxidase to produce cholestenone has been used
as a measure of lipid phase and stability of cholesterol in the
membrane (9,28). We ﬁnd that the addition of cholestenone
has two effects on vesicles of DOPC, DPPC, and cholesterol.
First, at low cholestenone concentrations (0–50% of total
sterol), the miscibility transition temperature is depressed,
although coexisting liquid phases are still observed below
the transition. When cholestenone is 50% of total sterol, the
liquid phase boundaries ﬂuctuate, implying that line tension
is small and that the transition temperature, as well as a
critical point, are probably nearby. Second, at higher cho-
lestenone fractions (.50–100% of total sterol), a solid phase
is observed. Our results indicate that a gradual conversion of
cholesterol to cholestenone by cholesterol oxidase can
change the phase state of the membrane. At higher temper-
atures, two coexisting liquid phases become one uniform
FIGURE 3 Fluorescence micrographs of vesicles produced from 1:1:1
DOPC/DPPC/sterol with 0.8 mol % TR-DPPE at 23C. Vesicles contain (a)
25-hydroxycholesterol, (b) cholesterol, (c) dihydrocholesterol, (d) epicho-
lesterol, (e) ergosterol, (f) no sterol (control), (g) androstenolone, (h)
cholestane, (i) cholestenone, and (j) coprostanol. As temperature is lowered,
phase coexistence is observed between either (top row) two liquid phases or
(bottom row) a solid and liquid phase. With time, liquid phases coalesce to
form one bright domain and one dark domain. Scale bars are 10 mm.
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liquid when cholesterol converts to cholestenone. At lower
temperatures, a solid phase can appear when cholesterol
converts to cholestenone.
DISCUSSION
Promoters and Inhibitors
Our classiﬁcation of promoter and inhibitor sterols in terms
of their ability to produce coexisting liquid domains in
vesicle membranes containing 1:1:1 DOPC/DPPC/sterol is
consistent with their previous designation as either pro-
moting or inhibiting the formation of DPPC-rich domains
based on ﬂuorescence quenching experiments (Table 1)
(4,11). We ﬁnd that the phases of DPPC-rich domains differ
strongly between promoter and inhibitor sterols. Vesicles
containing promoter sterols exhibit two coexisting liquid
phases, whereas vesicles containing inhibitor sterols exhibit
coexisting solid and liquid phases. On average, vesicles
containing promoter sterols have larger area fractions of
dark, ordered, DPPC-rich domains. Area fractions increase
as temperature decreases, consistent with more DPPC-rich
phases at lower temperatures (4). Values for the fraction of
dark area do not fall in exactly the same sterol order as values
for ﬂuorescence quenching (Table 1). This result is not
surprising since our vesicles contain the unsaturated lipid
DOPC rather than the quencher 12doxyl-stearoylPC and
incorporate more sterol (33% vs. 15%) (4).
Wenz and Barrantes have suggested that a sterol’s ability
to promote DPPC-rich phases in membranes may be cor-
related with higher sterol hydrophobicity. They compiled
and calculated values for the log of the partition coefﬁcient
(LogP) of sterols between octanol and water (29). We ﬁnd no
clear correlation between this measure of hydrophobicity and
either our own measurements of phase behavior and dark
area fraction or published values of ﬂuorescence quenching
(Table 1).
Sterol requirements
We are particularly interested in the question of why sterols
produce coexisting liquid domains in bilayer phospholipid
membranes. What structural components are required for
a sterol to mimic cholesterol’s effect on lipid miscibility?
Other researchers have previously asked what is required for
a sterol to be ‘‘functionally competent’’ (1) or ‘‘membrane
active’’ (30). We will discuss each below.
Bloch lists several attributes required for cholesterol’s
functional competence in membranes, among which are 1),
a ﬂat, rigid fused ring system, 2), the absence of methyl
groups on the a-face, 3), an equatorial 3-hydroxy group, 4),
bridgehead methyl groups at the C10 and C18 positions, and
5), an unmodiﬁed branched, isooctyl chain (1). Using our
results above, we evaluate these criteria with respect to lipid
miscibility. If part of cholesterol’s ‘‘functional competence’’
involves the production of coexisting liquid phases, then we
expect all sterols that follow Bloch’s criteria to be promoters.
FIGURE 4 Area fraction of dark phase of vesicles produced from 1:1:1
DOPC/DPPC/sterol with 0.8 mol % TR-DPPE. In general, vesicles
containing liquid domains have larger area fractions of dark domains. As
temperature decreases, the fraction of dark area either remains constant (25-
hydroxysterol and ergosterol) or decreases. Area fractions are not reported at
29C for membranes containing dihydrocholesterol and coprostanol because
membranes are in one uniform phase at this temperature.
FIGURE 5 Transition temperatures (top) and vesicle micrographs
(bottom) for vesicles of 1:1:(1 x):x DOPC/DPPC/cholesterol/cholestenone
with 0.8 mol % TR-DPPE. Coexisting liquid phases are observed below the
miscibility transition temperature in membranes with more cholesterol (:),
and solid and liquid phases are observed below the melting transition in
membranes with more cholestenone (n). In membranes with an equal ratio of
cholesterol and cholestenone (d), ﬂuctuations at domains boundaries relax
slowly (;1–10 s) and dark domains may contain a solid phase. Vesicles
contain x¼ 0%, 25%, 50%, 75%, and 100% cholestenone (from left to right)
and are imaged at 16C. All scale bars are 20 mm.
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For criterion 1, all of our sterols possess rigid fused rings.
However, coprostanol does not fulﬁll the requirement of
ﬂatness. Comparing coprostanol to dihydrocholesterol, the
two sterols differ only in the linkage of the ﬁrst two rings.
Coprostanol is curved due to a cis fusion of the A and B rings
(31), which likely prevents it from packing closely with
neighboring phospholipids and explains why it is an inhib-
itor. Vesicles containing coprostanol exhibit coexisting solid
and liquid phases, whereas vesicles containing dihydrocho-
lesterol exhibit coexisting liquid phases. For criterion 2,
lanosterol is our only sterol with methyl groups on the
a-face, and it does not consistently produce coexisting liquid
domains. Hence, within our set of sterols, criterion 2 is valid.
The enhanced planarity of cholesterol with respect to
lanosterol may explain its ability to alter the ordering and
phase behavior of lipids (32,33). For criterion 3, three of our
sterols do not possess equatorial hydroxyl groups at the 3
position: cholestane has a hydrogen, cholestenone has a
ketone group, and epicholesterol has an axial hydroxyl
group. Cholestane and cholestenone are inhibitors, yet the
promoter epicholesterol behaves like cholesterol in its ability
to produce coexisting liquid domains in vesicles, in its
fraction of dark area, and in its miscibility transition tem-
perature. Given our set of sterols, the criterion for a hydroxyl
group is valid, but the criterion for the group to be equatorial
is not important for miscibility phase behavior. For criterion
4, only androstenolone is missing the C10 methyl group, and
it is an inhibitor sterol. However, androstenolone is not
a sufﬁcient test of criterion 4 since it also violates criterion 5.
For criterion 5, several sterols do not possess unmodiﬁed
isooctyl chains, including the promoter sterols of ergosterol
and 25-hydroxycholesterol. Hence, the criterion for isooctyl
chains is not sufﬁcient to explain miscibility phase behavior.
Overall, we conclude that Bloch’s requirements for func-
tionally competent sterols are more strict than necessary to
predict the formation of liquid phases, particularly for the
promoter sterol epicholesterol (without an equatorial hy-
droxyl group) and the promoter sterols ergosterol and
25-hydroxycholesterol (with modiﬁed isooctyl chains).
Barenholz presents less stringent requirements for ‘‘mem-
brane active sterols’’, which usually predict our observed
formation of liquid phases. A membrane active sterol is
deﬁned as affecting short- and long-range lipid order within
membranes, minimizing volume, and decreasing membrane
permeability. Speciﬁcally, the sterol should possess 1), a ﬂat,
fused ring system, 2), a hydroxyl or other small polar group
at position 3, 3), a ‘‘cholesterol-like’’ tail, and 4), a small
area per molecule (,40 A˚2 when assembled at the air/water
interface at a surface pressure of 12 mN/m) (30). As an
example of applying rule 4, cholestenone is an inhibitor.
Although it satisﬁes rules 1–3, it violates rule 4 since it has
an area per molecule of 52 A˚2 in a monolayer at 12 mN/m
(34). The rules above correctly predict the observed for-
mation of liquid phases except in the case of 25-hydroxy-
cholesterol, which has an alkyl tail that terminates in a
hydroxyl group that is not ‘‘cholesterol-like’’. We do not
know how 25-hydroxycholesterol orients in the membrane
or exactly why its miscibility transition temperature is high
with a large spread in values (see Materials and Methods
section).
TABLE 1 Summary of data for vesicles produced from 1:1:1 DOPC/DPPC/sterol with 0.8 mol % TR-DPPE
Giant vesicles of 1:1:1 DOPC/DPPC/sterol
Transition temp. (C) % Dark area (23C) % Dark area (29C) DQuench (23C) DQuench (29C) LogP
LIQUID DOMAINS
25-OH-cholesterol 48 6 11 41 6 3 (N ¼ 14) 41 6 3 (N ¼ 17) 0.21 6 0.04 0.23 6 0.07 7.71
Cholesterol 29 6 1 52 6 2 (N ¼ 33) 48 6 2 (N ¼ 34) 0.23 6 0.03 0.22 6 0.03 8.71
Dihydrocholesterol 26 6 2 60 6 1 (N ¼ 16) – 0.29 6 0.04 0.24 6 0.03 –
Epicholesterol 29 6 1 46 6 2 (N ¼ 20) 35 6 3 (N ¼ 14) 0.23 6 0.02 0.19 6 0.01 8.71
Ergosterol 38 6 3 29 6 2 (N ¼ 23) 29 6 2 (N ¼ 24) 0.44 6 0.04 – 8.86
SOLID DOMAINS
No sterol 35 6 1 33 6 2 (N ¼ 17) 21 6 2 (N ¼ 14) 0.12 6 0.02 0.08 6 0.01 –
Androstenolone 36 6 1 39 6 2 (N ¼ 11) 26 6 1 (N ¼ 15) (0.01 6 0.02) (0.00 6 0.0.2) (2.77)
Cholestane 37 6 2 30 6 1 (N ¼ 20) 21 6 1 (N ¼ 18) 0.07 6 0.02 0.07 6 0.02 10.31
Cholestenone 29 6 3 9 6 2 (N ¼ 3) 1 6 0.2 (N ¼ 3) 0.05 6 0.03 0.04 6 0.02 8.54
Coprostanol 25 6 2 6 6 2 (N ¼ 5) – 0.05 6 0.01 0.02 6 0.01 –
NO DOMAINS
Lanosterol – – – 0.13 6 0.02 0.10 6 0.02 –
As temperature is decreased, a transition is observed from one uniform phase to either two coexisting liquid phases (‘‘Liquid domains’’) or a solid and liquid
phase (‘‘Solid domains’’). To calculate the fraction of dark, ordered area at 23C and 29C, images of both hemispheres of N vesicles were captured. Xu and
London (4) evaluated the ﬂuorescence of a probe that partially partitions with DPPC in vesicles containing the quencher 12 doxyl-stearoyl PC and a variety of
sterols. Demixing of the dye and quencher resulted in a reduction in quenching with respect to a uniformly mixed control. Hence, large changes in
ﬂuorescence quenching (‘‘DQuench’’) are attributed to enhanced formation of DPPC-enriched domains in vesicles by promoter sterols (4,11). LogP
represents the log of the sterol partition coefﬁcient in octanol/water as compiled and calculated by Wenz and Barrantes (29) and does not correlate with sterol
phase. Quenching and logP results are not available in the literature for androstenolone but are instead quoted for androstenol and placed in parentheses.
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Headgroups and alkyl chains
Several researchers have investigated the headgroup and
alkyl chain moieties of sterols in depth. For example, the
3-hydroxy headgroup is equatorial in cholesterol and axial in
epicholesterol. Cholesterol and epicholesterol are similar in
that both produce comparable pressure-area isotherms
(34). However, cholesterol and epicholesterol differ in the
condensation of monolayers, the collapse pressure of
monolayers, and the enthalpy of the 18:1-18:0 PC bilayer
gel transition (15,34). Comparing to our own results, we ﬁnd
that the substitution of epicholesterol for cholesterol makes
no significant difference in vesicle phase behavior, transition
temperature, or area of dark phase.
Other studies have replaced the hydroxyl headgroup of
cholesterol with a ketone, an acetate, or an ether and found
that the compressibility of DPPC/sterol monolayers is lowest
for the hydroxy-sterols (35). Similarly, replacing the
hydroxyl headgroup of cholesterol with a ketone to produce
6-ketosterol renders the sterol less effective at reducing
monolayer lateral elasticity (36). Returning to our own
results on hydroxysterols versus ketosterols, we ﬁnd that
cholestenone is an inhibitor. The structural reason that
cholestenone is an inhibitor is likely because its ketone
headgroup lacks the ability of a hydroxyl group to directly
hydrogen bond with the ester linkage of phosphatidylcholine
lipid acyl chains (37).
With respect to the alkyl-chain structure of sterols, lipid
vesicles are more permeable when they contain sterols with
alkyl chains that are longer and more unsaturated than the
alkyl chain of cholesterol (38). In a separate experiment, a
group of cholesterol analogs with branched and unbranched
chains containing 3–10 carbons all exhibited roughly equal
area condensation in monolayers of DPPC or 18:0-18:1PC
(28). Sterols with unbranched alkyl chains had smaller
molecular areas and smaller collapse pressures than those
with branched chains (28). Although unbranched cholesterol
analogs ﬁt the requirement of a smaller molecular area for
a ‘‘membrane active sterol’’ (30), it is unclear if an
unbranched tail qualiﬁes as ‘‘cholesterol-like’’. In any
case, it is clear that membrane active sterols require an alkyl
chain. Androstenol (5-androsten-3b-ol) is similar to andros-
tenolone, lacks an alkyl chain, has no signiﬁcant condensing
effect on monolayers (28), and has a much smaller effect on
monolayer lateral elasticity than cholesterol (36).
Applying this information to our results, it is difﬁcult
to ﬁnd correlations that consistently apply between the
membrane phases we observe and previous measurements
of membrane order and permeability. We ﬁnd that
membrane phase often, but not always, correlates with the
general magnitude of area condensation of sterols with
oleoyl-stearoyl PC (34), the solubilization of sterols in
sonicated eggPC extracts, the decrease in vesicle perme-
ability (10), or the equilibrium constants for lipid dimer
exchange (31).
A similar conclusion applies to monolayers. A variety of
cholesterol analogs condense lipid monolayers (DPPC or
stearoyl-oleoylPC in this case) (28), but not all produce
immiscible liquid phases in lipid monolayers (DPPC or
palmitoyl-sphingomyelin in this case) (35,39). As another
example, sterol molecular area in monolayers predicts the
temperature of the inverted hexagonal phase transition in
bilayers of lipids and many sterols, with the striking excep-
tion of androstenol (40).
Cholesterol, ergosterol, and lanosterol
Historically, there has been intense theoretical and experi-
mental interest in the natural sterols of cholesterol, ergos-
terol, and lanosterol. From the theoretical side, molecular
dynamics simulations for membranes of 8:1 DMPC/sterol
ﬁnd similar ordering, number of gauche defects, molecular
area, and electron density for all three sterols of cholesterol,
ergosterol, and lanosterol. At 1:1 DMPC/sterol, these
simulations conclude that cholesterol has stronger condens-
ing compared to lanosterol (41). Simulations and experi-
ment ﬁnd evidence of a liquid-liquid coexistence region for
bilayers of cholesterol and palmitoyl-petroselinoylPC
(PPetPC), but not for bilayers of lanosterol and PPetPC
(33).
From the experimental side, the effects of lanosterol on
lipid membranes are typically less pronounced than of
cholesterol and ergosterol. For example, cholesterol reduces
vesicle permeability more than lanosterol (42). Similarly, the
microviscosity of eggPC/cholesterol membranes is greater
than of eggPC/lanosterol membranes as measured by ﬂuo-
rescence microscopy (43). Nuclear magnetic resonance ﬁnds
that sterols produce conformational ordering of saturated
lipid chains of dimyristoylPC and PPetPC in the hierarchy
ergosterol . cholesterol . lanosterol. For the mixed
saturated and unsaturated chains of palmitoyl-oleoylPC,
ordering occurs as cholesterol . ergosterol ; lanosterol
(33,44). For the unsaturated chains of DOPC, ordering
occurs as cholesterol . lanosterol (45). Cholesterol and
ergosterol also produce more membrane order than lano-
sterol as measured by a spin probe incorporated in vesicles of
bovine brain lipids (46). However, smaller concentrations of
lanosterol (15%) than cholesterol (25%) are required to
diminish the endothermic melting peak of PPetPC (33).
Implications
What can we conclude from the discussion above? We often
think of cholesterol as uniquely suited to the task of altering
membrane structure, as beﬁtting a molecule at the end of a
biochemical pathway and optimized through evolution.
Cholesterol is certainly more effective in this role than
lanosterol. However, in terms of cholesterol’s ability to
produce coexisting liquid phases in membranes of DOPC,
DPPC, and sterol, it is not clearly more effective than
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ergosterol or the other promoter sterols of dihydrocholes-
terol, epicholesterol, or 25-hydroxycholesterol. Although
many promoter sterols are associated with low vesicle
permeability, low molecular area, and high compressibility,
none of these parameters individually predicts the phase
behavior we observe in vesicles. Instead, we ﬁnd that the
conglomerate description of ‘‘membrane active sterols’’ (30)
applies well to all but one of the promoter sterols in this
study. All promoter sterols may sufﬁciently fulﬁll the role of
altering membrane phase behavior, and the speciﬁc sterol
utilized by different biological systems may depend further
on speciﬁc biochemical processes of each system’s cell cycle
(47).
CONCLUSION
In summary, we ﬁnd coexisting liquid phases in bilayer lipid
membranes containing those sterols previously characterized
as promoting the formation of DPPC-rich phases. Although
detailed phase diagrams are required to completely compare
the effectiveness of each promoter sterol in producing liquid
phases, it seems likely that the following structural features
that fulﬁll requirements of ‘‘membrane active sterols’’ play
an important role: 1), ﬂat, fused rings, 2), a hydroxyl or other
small polar group at position 3, 3), a ‘‘cholesterol-like’’ tail,
and 4), a small area per molecule (30).
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